Literature DB >> 22732040

Living donor practices in the United States.

Didier A Mandelbrot1, Martha Pavlakis.   

Abstract

Living kidney donation is a common procedure in the United States. Substantial variation exists between transplant centers in their protocols and exclusion criteria for potential living donors. In the absence of clinical trial data to guide decisions about exclusion criteria, knowledge of current practices is an important first step in guiding the formulation of donor protocols and future studies. Certain trends in living donation practices have become apparent from surveys of transplant programs over the past few decades. Over the past 25 years, opposition to living unrelated donation in the United States has gone from strong to essentially nonexistent. With respect to donor age, programs have become less strict regarding upper age limits but stricter regarding younger donor candidates. Protocols regarding kidney function, blood pressure, and diabetes screening also continue to evolve. Although donor follow-up is mandated by the Organ Procurement and Transplantation Network for 2 years after donation, a majority of donors are lost to follow-up by 1 year. The most commonly cited barriers to donor follow-up include donor inconvenience, cost issues including reimbursement to care providers, and direct and indirect costs to donors. In this article, we review the current knowledge about living donor practices in the United States.
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22732040      PMCID: PMC3384489          DOI: 10.1053/j.ackd.2012.04.010

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  40 in total

1.  Evolution of attitudes at U.S. transplant centers toward kidney donation by friends and altruistic strangers.

Authors:  A Spital
Journal:  Transplantation       Date:  2000-04-27       Impact factor: 4.939

Review 2.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

3.  Long-term (20-37 years) follow-up of living kidney donors.

Authors:  Thiagarajan Ramcharan; Arthur J Matas
Journal:  Am J Transplant       Date:  2002-11       Impact factor: 8.086

Review 4.  A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines.

Authors:  Francis Delmonico
Journal:  Transplantation       Date:  2005-03-27       Impact factor: 4.939

5.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

8.  Blood pressure and renal function after kidney donation from hypertensive living donors.

Authors:  Stephen C Textor; Sandra J Taler; Nancy Driscoll; Timothy S Larson; James Gloor; Matthew Griffin; Fernando Cosio; Thomas Schwab; Mikel Prieto; Scott Nyberg; Michael Ishitani; Mark Stegall
Journal:  Transplantation       Date:  2004-07-27       Impact factor: 4.939

9.  Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex.

Authors:  Nathan D Wong; Gaurav Thakral; Stanley S Franklin; Gil J L'Italien; Milagros J Jacobs; Joanna L Whyte; Pablo Lapuerta
Journal:  Am Heart J       Date:  2003-05       Impact factor: 4.749

10.  Measured and estimated GFR in healthy potential kidney donors.

Authors:  Andrew D Rule; Hiie M Gussak; Gregory R Pond; Erik J Bergstralh; Mark D Stegall; Fernando G Cosio; Timothy S Larson
Journal:  Am J Kidney Dis       Date:  2004-01       Impact factor: 8.860

View more
  17 in total

1.  Obesity increases the risk of end-stage renal disease among living kidney donors.

Authors:  Jayme E Locke; Rhiannon D Reed; Allan Massie; Paul A MacLennan; Deirdre Sawinski; Vineeta Kumar; Shikha Mehta; Roslyn B Mannon; Robert Gaston; Cora E Lewis; Dorry L Segev
Journal:  Kidney Int       Date:  2016-12-29       Impact factor: 10.612

2.  Correlation of preoperative imaging characteristics with donor outcomes and operative difficulty in laparoscopic donor nephrectomy.

Authors:  Fides R Schwartz; Brian I Shaw; Reginald Lerebours; Federica Vernuccio; Francesca Rigiroli; Fernando Gonzalez; Sheng Luo; Aparna S Rege; Deepak Vikraman; Lynne Hurwitz-Koweek; Daniele Marin; Kadiyala Ravindra
Journal:  Am J Transplant       Date:  2019-10-23       Impact factor: 8.086

3.  Perspectives on implementing mobile health technology for living kidney donor follow-up: In-depth interviews with transplant providers.

Authors:  Ann K Eno; Jessica M Ruck; Sarah E Van Pilsum Rasmussen; Madeleine M Waldram; Alvin G Thomas; Tanjala S Purnell; Jacqueline M Garonzik Wang; Allan B Massie; Fawaz Al Almmary; Lisa M Cooper; Dorry L Segev; Michael A Levan; Macey L Henderson
Journal:  Clin Transplant       Date:  2019-07-01       Impact factor: 2.863

4.  Health Insurance Trends in United States Living Kidney Donors (2004 to 2015).

Authors:  J R Rodrigue; A Fleishman
Journal:  Am J Transplant       Date:  2016-05-23       Impact factor: 8.086

5.  Long-term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation.

Authors:  Lara M Fahmy; Allan B Massie; Abimereki D Muzaale; Serena M Bagnasco; Babak J Orandi; Jennifer L Alejo; Brian J Boyarsky; Saad K Anjum; Robert A Montgomery; Nabil N Dagher; Dorry L Segev
Journal:  Transplantation       Date:  2016-06       Impact factor: 4.939

6.  Living Kidney Donor Phenotype and Likelihood of Postdonation Follow-up.

Authors:  Rhiannon D Reed; Brittany A Shelton; Paul A MacLennan; Deirdre L Sawinski; Jayme E Locke
Journal:  Transplantation       Date:  2018-01       Impact factor: 4.939

Review 7.  Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Authors:  Raymond Vanholder; Lieven Annemans; Edwina Brown; Ron Gansevoort; Judith J Gout-Zwart; Norbert Lameire; Rachael L Morton; Rainer Oberbauer; Maarten J Postma; Marcello Tonelli; Wim Van Biesen; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2017-05-30       Impact factor: 28.314

8.  How safe is unilateral nephrectomy?

Authors:  Joseph I Shapiro; Larry D Dial
Journal:  Hypertension       Date:  2012-10-15       Impact factor: 10.190

9.  The unjustified classification of kidney donors as patients with CKD: critique and recommendations.

Authors:  Arthur J Matas; Hassan N Ibrahim
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

10.  Preventive intervention for living donor psychosocial outcomes: feasibility and efficacy in a randomized controlled trial.

Authors:  M A Dew; A F DiMartini; A J DeVito Dabbs; A Zuckoff; H P Tan; M L McNulty; G E Switzer; K R Fox; J B Greenhouse; A Humar
Journal:  Am J Transplant       Date:  2013-08-07       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.